EcoDrugPlus

Monoamine Oxidase B

Ensembl ID : ENSCHYG00000020035
Gene Symbol: MAOB
1 Cross references
333 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSCHYG00000016817
Gene Symbol: MGLL
1 Cross references
209 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSCHYG00000013419
Gene Symbol: MLNR
1 Cross references
163 Possible Orthologues:

Myeloperoxidase

Ensembl ID : ENSCHYG00000012488
Gene Symbol: MPO
1 Cross references
182 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSCHYG00000017011
Gene Symbol: NPR1
1 Cross references
186 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSCHYG00000020493
Gene Symbol: NPR2
1 Cross references
260 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSCHYG00000026248
Gene Symbol: NPR3
1 Cross references
210 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSCHYG00000009114
Gene Symbol: NPY2R
1 Cross references
248 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSCHYG00000016193
Gene Symbol: NPY5R
1 Cross references
137 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSCHYG00000024836
Gene Symbol: NTSR1
1 Cross references
208 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSCHYG00000020989
Gene Symbol: NTRK1
1 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSCHYG00000013465
Gene Symbol: NTRK2
1 Cross references
288 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).